77. Biosimilars are not generic biologics. Guest, Jordan Paradise.
Published November 25, 2016
36 min
    Add to queue
    Copy URL
    Show notes
    Loyola Chicago law professor Jordan Paradise joins us to discuss some of her recent work in life sciences law. We start with a review of some of the regulatory issues involving e-cigarettes and discuss the 2016 FDA regulations. We then move into a discussion of FDA regulation of biologics and biosimilars and Jordan explains naming and substitution issues.
        0:00:00 / 0:00:00